Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Dovato interactions?

See the DrugPatentWatch profile for Dovato

What drug interactions does Dovato (dolutegravir + lamivudine) have?

Dovato contains dolutegravir (an integrase inhibitor) and lamivudine (a nucleoside reverse transcriptase inhibitor). Drug–drug interactions mostly come from dolutegravir, which can be affected by medicines that change stomach acidity, gut drug transport, or liver enzymes.

Common interaction themes include:
- Medicines that reduce stomach acid can change how well dolutegravir absorbs.
- Medicines that affect drug transporters (notably certain chelators and transporter inducers) can lower or raise dolutegravir exposure.
- Some other antiretrovirals or certain antibiotics/anticonvulsants can be unsafe or need dose/timing changes.
- Drugs that affect kidney function or compete for renal elimination can increase lamivudine levels.

Because the exact risk depends on the specific product, dose, and timing, interaction checking should be done with your full medication list (including OTC drugs and supplements).

Which “common meds” reduce Dovato absorption?

Dovato can interact with antacids and other acid-reducing agents because dolutegravir absorption is pH-dependent. The interaction is often managed by timing doses (for example, separating dolutegravir from antacids) rather than always avoiding the medicine, but the safe schedule depends on the exact drug.

Typical categories that can matter:
- Antacids containing aluminum or magnesium
- Buffered medications that affect gastric pH
- Proton pump inhibitors (PPIs)
- H2 blockers

Does Dovato interact with supplements like calcium, iron, or multivitamins?

Yes. Dolutegravir can bind to polyvalent cations (such as calcium, iron, and magnesium), which can reduce dolutegravir absorption. The usual workaround is to separate doses by a specific time window, but the correct separation depends on the supplement and your dosing schedule.

Which diabetes, cholesterol, or seizure medicines can be a problem?

Some anticonvulsants and certain other medicines can change drug levels by inducing or inhibiting metabolic pathways and transporters. These changes can make dolutegravir levels too low (risk of loss of HIV control) or, less commonly, too high (higher side-effect risk). If you take:
- Seizure medicines (especially enzyme inducers)
- Some antibiotics or antifungals
- Some steroid or immunosuppressant medicines

you should review interactions before starting, stopping, or switching.

Can Dovato be taken with other HIV medicines?

Often, Dovato is used as a complete regimen (two active drugs), so adding other HIV drugs is usually done only under clinician guidance (for reasons like treatment history, resistance, or special circumstances). Some antiretrovirals can overlap mechanisms or change drug levels.

The safest approach is: do not combine Dovato with other antiretrovirals unless your prescriber specifically directs it.

What about kidney-related interactions (lamivudine)?

Lamivudine is cleared by the kidneys. If you take medicines that are also renally cleared or that can affect kidney function, lamivudine levels can increase, which may raise the chance of side effects. The prescriber may adjust timing or dosing if kidney function is reduced.

If you have kidney impairment, the interaction checklist should include:
- Your latest creatinine/eGFR
- Any nephrotoxic drugs
- Whether other medicines change renal clearance

What should people watch for after starting a new medicine with Dovato?

Patients should contact their clinician promptly if they notice:
- New gastrointestinal symptoms that are persistent after adding an acid reducer or supplement
- Unusual fatigue, nausea, or rash
- Signs of reduced HIV drug effectiveness (for example, if they miss doses during the first weeks after a medication change)
- Any new neurologic symptoms

Also, if a medicine is started that is known to strongly affect drug levels (such as certain anticonvulsants or acid reducers), confirm the interaction plan immediately rather than waiting for symptoms.

Tell me your exact meds and I’ll check interaction risk

If you paste your current medication list (prescription + OTC + supplements) with doses and timing, I can flag which ones typically interact with Dovato and what the usual management strategy is (avoid vs. separate doses vs. adjust).



Other Questions About Dovato :

dovato 50/300 Dovato price uk? Dovato price? Dovato vs biktarvy weight gain? Dovato cost in canada? Dovato clinical trials? Dovato cost with insurance?

AI-Drug Label Prescribing Information Alignment Report

82
82%
Grade B

Good

Mostly Aligned

Patient Risk: Low

Summary

The claims largely reflect label content on drug interactions and acid-reducing agents; strong coverage of dolutegravir interactions; comprehensive regarding OTC and dietary interactions. Notably, explicit contraindications, boxed warnings, pregnancy/breastfeeding guidance, pediatric safety, and hepatic impairment dosing are not addressed.


Category Scores

Dosage
82
Good
DrugInteractions
92
Excellent
SpecificPopulations
88
Good
AdverseReactions
70
Fair
Administration
86
Good

Accurate Statements

Dovato contains dolutegravir (an integrase inhibitor) and lamivudine (a nucleoside reverse transcriptase inhibitor).
Label section 11 (DESCRIPTION)
Dovato can interact with antacids and other acid-reducing agents because dolutegravir absorption is pH-dependent.
Label section 7.4 (drug interactions)
Lamivudine is cleared by the kidneys.
Label section 7.4 (drug interactions) and pharmacology sections on lamivudine clearance
Dovato dosing adjustments are described for coadministered drugs (e.g., higher dolutegravir doses with carbamazepine or rifampin).
Label sections 2.3 and 7.4

Unsupported Statements


Contradictions


Important Omissions

Contraindications, boxed warnings, pregnancy and lactation guidance, pediatric safety, hepatic impairment dosing guidance, and full adverse event monitoring details are not addressed by the claims.
Importance: High

Safety Assessment

Potential Patient Risk: Low
The claims accurately describe many interactions and safety concepts but omit explicit contraindications, boxed warnings, pregnancy/pediatric guidance, and comprehensive adverse event monitoring.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Missing explicit contraindications, boxed warnings, pregnancy/lactation guidance, and pediatric safety/dosing in the claims; add sections 4, 5, 8.1/8.2/8.3/8.4 as applicable.

Suggested Improvement
Incorporate explicit contraindications and boxed warnings; include pregnancy, lactation, pediatric safety data; include hepatic impairment dosing if applicable; provide monitoring guidance and storage/handling details as per label.

Drug Brand Mention Assessment

Branding Score
68
Visibility
90
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • Dovato contains dolutegravir (an integrase inhibitor) and lamivudine (a nucleoside reverse transcriptase inhibitor).
  • Drug–drug interactions mostly come from dolutegravir, which can be affected by medicines that change stomach acidity, gut drug transport, or liver enzymes.
  • Medicines that reduce stomach acid can change how well dolutegravir absorbs.
  • Dovato can interact with antacids and other acid-reducing agents because dolutegravir absorption is pH-dependent.
  • Dolutegravir can bind to polyvalent cations (such as calcium, iron, and magnesium), which can reduce dolutegravir absorption.
Differentiators
  • Often, Dovato is used as a complete regimen (two active drugs), so adding other HIV drugs is usually done only under clinician guidance (for reasons like treatment history, resistance, or special circumstances). Some antiretrovirals can overlap mechanisms or change drug levels.
  • The safest approach is: do not combine Dovato with other antiretrovirals unless your prescriber specifically directs it.
  • Dovato can interact with antacids and other acid-reducing agents because dolutegravir absorption is pH-dependent.
  • Dolutegravir can bind to polyvalent cations (such as calcium, iron, and magnesium), which can reduce dolutegravir absorption.

Pricing Perception: Not Mentioned